Patton SE - Search Results

1

Effect of oral administration of tri-o-cresyl phosphate on in vitro phosphorylation of membrane and cytosolic proteins from chicken brain.

Patton SE, O'Callaghan JP, Miller DB, Abou-Donia MB. Patton SE, et al. J Neurochem. 1983 Sep;41(3):897-901. doi: 10.1111/j.1471-4159.1983.tb04826.x. J Neurochem. 1983. PMID: 6875574

2

Relationship of tri-O-cresyl phosphate-induced delayed neurotoxicity to enhancement of in vitro phosphorylation of hen brain and spinal cord proteins.

Patton SE, Lapadula DM, Abou-Donia MB. Patton SE, et al. J Pharmacol Exp Ther. 1986 Nov;239(2):597-605. J Pharmacol Exp Ther. 1986. PMID: 3772811

3

Changes in in vitro brain and spinal cord protein phosphorylation after a single oral administration of tri-o-cresyl phosphate to hens.

Patton SE, Lapadula DM, O'Callaghan JP, Miller DB, Abou-Donia MB. Patton SE, et al. J Neurochem. 1985 Nov;45(5):1567-77. doi: 10.1111/j.1471-4159.1985.tb07228.x. J Neurochem. 1985. PMID: 4045464

4

Partial characterization of endogenous phosphorylation conditions for hen brain cytosolic and membrane proteins.

Patton SE, Lapadula DM, Abou-Donia MB. Patton SE, et al. Brain Res. 1985 Feb 25;328(1):1-14. doi: 10.1016/0006-8993(85)91316-2. Brain Res. 1985. PMID: 3971166

5

Characterization of delayed neurotoxicity in the mouse following chronic oral administration of tri-o-cresyl phosphate.

Lapadula DM, Patton SE, Campbell GA, Abou-Donia MB. Lapadula DM, et al. Among authors: patton se. Toxicol Appl Pharmacol. 1985 Jun 15;79(1):83-90. doi: 10.1016/0041-008x(85)90370-9. Toxicol Appl Pharmacol. 1985. PMID: 4049409

6

Comparison of endogenous phosphorylation of hen and rat spinal cord proteins and partial characterization of optimal phosphorylation conditions for hen spinal cord.

Patton SE, Lapadula DM, Abou-Donia MB. Patton SE, et al. Neurochem Int. 1985;7(1):111-23. doi: 10.1016/0197-0186(85)90015-4. Neurochem Int. 1985. PMID: 20492906

7

Activation of the ras-mitogen-activated protein kinase pathway and phosphorylation of ets-2 at position threonine 72 in human ovarian cancer cell lines.

Patton SE, Martin ML, Nelsen LL, Fang X, Mills GB, Bast RC Jr, Ostrowski MC. Patton SE, et al. Cancer Res. 1998 May 15;58(10):2253-9. Cancer Res. 1998. PMID: 9605774

8

Bladder cancer.

Patton SE, Hall MC, Ozen H. Patton SE, et al. Curr Opin Oncol. 2002 May;14(3):265-72. doi: 10.1097/00001622-200205000-00003. Curr Opin Oncol. 2002. PMID: 11981270 Review.

9

Phase I/II study of 19-nor-1alpha-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancer.

Schwartz GG, Hall MC, Stindt D, Patton S, Lovato J, Torti FM. Schwartz GG, et al. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8680-5. doi: 10.1158/1078-0432.CCR-05-1237. Clin Cancer Res. 2005. PMID: 16361554 Clinical Trial.

10

Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma.

Clark PE, Hall MC, Miller A, Ridenhour KP, Stindt D, Lovato JF, Patton SE, Brinkley W, Das S, Torti FM. Clark PE, et al. Among authors: patton se. Urology. 2004 Jun;63(6):1061-5. doi: 10.1016/j.urology.2004.01.035. Urology. 2004. PMID: 15183950 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters